DRW Securities shaved off 64.3% of its Deere & Company stake in Q4, dumping 1,983 shares and hanging on to just 1,103. Several other firms followed suit, either trimming or barely dipping their toes ...

Wedbush just dialed down Airbnb’s price target from $175 to $150, citing a foggy economic outlook clouded by tariffs, ...

Representative Jefferson Shreve recently dipped into Vertex Pharmaceuticals stock, buying between $15,001 and $50,000 worth on March 13th. He revealed this transaction in a disclosure dated April 11th ...

Lockheed Martin shares nudged up 0.7% during a trading session that saw volume plummet 77% below average, making more of a ...

F M Investments boosted its stake in Regeneron Pharmaceuticals by 8.5% in Q4, grabbing 7,003 shares worth nearly $5 million.

Bristol Myers Squibb has teamed up with Optellum to sharpen its lung cancer game using artificial intelligence, proving even Big Pharma knows it’s smarter to bring robots to a knife fight. This ...

Investment firm Baird cut its price target for Cigna from $388 to $362 but kept its Outperform rating intact. The move ...

Seneschal Advisors LLC just caffeinated their portfolio by brewing up a fresh $711,000 stake in Starbucks during the fourth ...

Automatic Data Processing saw a 45% surge in put option trading, signaling nervous investors prepping for stormy weather.

Coign Capital Advisors just waltzed into Marsh & McLennan Companies with a cool $581,000, grabbing 2,735 shares like they ...

RBC Capital is still sweet on Boston Scientific, holding firm on its $116 price target and an Outperform rating. The analyst ...

Heritage Trust Co. recently grabbed 32,999 shares of CVS Health worth nearly $1.5 million, making its latest move in the financial chess game. Several institutional investors joined the prescription ...